| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue | 4.0B +2.1% | 3.9B +13.0% | 3.5B -0.7% | 3.5B -2.2% | 3.6B |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 4.0B +2.1% | 3.9B +13.0% | 3.5B -0.7% | 3.5B -2.2% | 3.6B |
| Operating Expenses | 2.4B +0.7% | 2.4B +9.0% | 2.2B -7.0% | 2.4B -4.1% | 2.5B |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 834.0M +0.4% | 831.0M +2.3% | 812.0M -2.8% | 835.0M +2.5% | 815.0M |
| Operating Income | 1.6B +4.2% | 1.5B +20.2% | 1.3B +12.9% | 1.1B +2.1% | 1.1B |
| EBITDA | 2.0B +3.4% | 1.9B +14.9% | 1.7B +10.2% | 1.5B -9.6% | 1.7B |
| Net Income | 1.1B +5.0% | 1.0B +24.2% | 807.0M +12.1% | 720.0M +3.7% | 694.0M |
| EPS (Basic) | $0.57 +5.6% | $0.54 +25.6% | $0.43 +10.3% | $0.39 +5.4% | $0.37 |
| EPS (Diluted) | $0.57 +5.6% | $0.54 +25.6% | $0.43 +10.3% | $0.39 +5.4% | $0.37 |
| Shares (Diluted) | 1.9B -0.3% | 1.9B -0.2% | 1.9B -0.1% | 1.9B -0.2% | 1.9B |